|
|
Volumn 39, Issue 2, 2004, Pages 195-203
|
|
Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides
a
|
|
Author keywords
Anti candida activity; Anti mycobacterial; Anti trichomonas; Quinoxaline 1,4 dioxides; SAR
|
|
Indexed keywords
6,7 DIFLUORO 3 METHYL 2 (3,4 DICHLOROBENZYLAMINO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (3,4 DICHLOROPHENYLAMINO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (3,4 DICHLOROPHENYLSULFONYL)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (3,4 DICHLOROPHENYLTHIO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (3,4 DIMETHOXYBENZYLAMINO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (3,4 DIMETHOXYPHENYLAMINO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (3,4 DIMETHOXYPHENYLSULFONYL)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (3,4 DIMETHOXYPHENYLTHIO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (3,4,5 TRIMETHOXYBENZYLAMINO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (3,4,5 TRIMETHOXYPHENYLAMINO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (3,5 DIMETHOXYBENZYLAMINO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (3,5 DIMETHOXYPHENYLAMINO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (4 FLUOROBENZYLAMINO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (4 FLUOROPHENYLAMINO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (4 FLUOROPHENYLTHIO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (4 METHOXYBENZYLAMINO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (4 METHOXYPHENYLAMINO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (4 METHOXYPHENYLSULFONYL)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 (4 METHOXYPHENYLTHIO)QUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 BENZYLAMINOQUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 PHENYLAMINOQUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 PHENYLSULFINYLQUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUOTO 3 METHYL 2 (4 FLUOROPHENYLSULFONYL)QUINOXALINE 1,4 DIOXIDE;
ANTIFUNGAL AGENT;
ANTIMYCOBACTERIAL AGENT;
ANTITRICHOMONAL AGENT;
METRONIDAZOLE;
RIFAMPICIN;
UNCLASSIFIED DRUG;
ANTIFUNGAL ACTIVITY;
ANTIPROTOZOAL ACTIVITY;
ARTICLE;
CANDIDA ALBICANS;
CANDIDA GLABRATA;
CANDIDA KRUSEI;
CANDIDA PARAPSILOSIS;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG SENSITIVITY;
DRUG SYNTHESIS;
ESCHERICHIA COLI;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
KLEBSIELLA PNEUMONIAE;
MINIMUM INHIBITORY CONCENTRATION;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PSEUDOMONAS AERUGINOSA;
STAPHYLOCOCCUS AUREUS;
TRICHOMONAS VAGINALIS;
VIBRIO ALGINOLYTICUS;
|
|
EID: 1342324049
PISSN: 02235234
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ejmech.2003.11.008 Document Type: Article |
|
Times cited : (106)
|
|
References (27)
|
